Switching antipsychotics to support the physical health of people with severe mental illness: a qualitative study of healthcare professionals' perspectives

被引:17
作者
Nash, Annabel [1 ,2 ]
Kingstone, Tom [1 ,3 ]
Farooq, Saeed [1 ,3 ]
Tunmore, Jessica [1 ,3 ]
Chew-Graham, Carolyn A. [1 ,3 ]
机构
[1] Midlands Partnership NHS Fdn Trust, Res & Innovat Dept, Stafford, England
[2] Staffordshire Univ, Sch Life Sci & Educ, Stoke On Trent, Staffs, England
[3] Keele Univ, Sch Med, Keele, Staffs, England
关键词
CARDIOVASCULAR RISK; DIABETES-MELLITUS; BIPOLAR DISORDER; SCHIZOPHRENIA; MORTALITY; RECOMMENDATIONS; TOLERABILITY; PREVALENCE; GUIDELINES; PREDICTORS;
D O I
10.1136/bmjopen-2020-042497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The side effects of antipsychotic medications (APs) can increase the risk of developing physical health conditions. Some APs pose a higher risk than others. Evidence suggests switching to lower risk APs can support physical health outcomes. We sought to explore the views of healthcare professionals about switching antipsychotics to support physical health in people with severe mental illness (SMI). Design A qualitative study with semi-structured interviews conducted with general practitioners (GPs), psychiatrists and mental health nurses. The main focus was to explore participants' views on the physical health of people with SMI, the impact of APs and decision-making about switching medication to support physical health. Data were analysed thematically using principles of constant comparison. Settings Participants recruited through primary care and one mental health trust in the West Midlands. Participants Interviews were conducted with 9 GPs, 10 psychiatrists and 4 mental health nurses. Results Awareness and knowledge of AP side-effects and risk profiles varied considerably between primary and secondary care clinicians. GPs reported limited awareness, while psychiatrists and nurses demonstrated a comprehensive understanding of AP risk profiles and side-effects. Mental health and control of symptoms were prioritised. Switching to promote physical health was considered as a reactive intervention, once side-effects or complications developed. There were a range of views over where responsibility lay for monitoring physical health and consideration of switching. Collaboration between primary and secondary care was identified as a way to address this. Conclusions This study presents multidisciplinary perspectives on awareness, decision making, perceived responsibility and barriers to switching APs to support physical health. Collaborative approaches that involve liaison between primary and secondary care, but tailored to the individual patient, may support switching, and present an opportunity to intervene to address the physical health inequalities experienced by individuals with SMI.
引用
收藏
页数:8
相关论文
共 32 条
[1]   Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis [J].
Bai, Zhihua ;
Wang, Guoqiang ;
Cai, Shangli ;
Ding, Xindi ;
Liu, Weiwei ;
Huang, Depei ;
Shen, Weidi ;
Zhang, Juncheng ;
Chen, Kui ;
Yang, Yuqing ;
Zhang, Lili ;
Zhao, Xiaochen ;
Ouyang, Qiong ;
Zhao, Jingping ;
Lu, Huafei ;
Hao, Wei .
SCHIZOPHRENIA RESEARCH, 2017, 185 :73-79
[2]  
Braun V., 2006, Qual Res Psychol, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
[3]  
Charmaz K., 2006, CONSTRUCTING GROUNDE, V1st
[4]   Risks of all-cause and suicide mortality in mental disorders: a meta-review [J].
Chesney, Edward ;
Goodwin, Guy M. ;
Fazel, Seena .
WORLD PSYCHIATRY, 2014, 13 (02) :153-160
[5]   The Physical Health of Individuals Receiving Antipsychotic Medication: A Qualitative Inquiry on Experiences and Needs [J].
Cocoman, Angela M. ;
Casey, Mary .
ISSUES IN MENTAL HEALTH NURSING, 2018, 39 (03) :282-289
[6]   BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment [J].
Cooper, Stephen J. ;
Reynolds, Gavin P. ;
Barnes, T. R. E. ;
England, E. ;
Haddad, P. M. ;
Heald, A. ;
Holt, R. I. G. ;
Lingford-Hughes, A. ;
Osborn, D. ;
McGowan, O. ;
Patel, M. X. ;
Paton, C. ;
Reid, P. ;
Shiers, D. ;
Smith, J. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (08) :717-748
[7]   Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls [J].
Correll, Christoph U. ;
Solmi, Marco ;
Veronese, Nicola ;
Bortolato, Beatrice ;
Rosson, Stella ;
Santonastaso, Paolo ;
Thapa-Chhetri, Nita ;
Fornaro, Michele ;
Gallicchio, Davide ;
Collantoni, Enrico ;
Pigato, Giorgio ;
Favaro, Angela ;
Monaco, Francesco ;
Kohler, Cristiano ;
Vancampfort, Davy ;
Ward, Philip B. ;
Gaughran, Fiona ;
Carvalho, Andre F. ;
Stubbs, Brendon .
WORLD PSYCHIATRY, 2017, 16 (02) :163-180
[8]   Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness A Randomized Clinical Trial [J].
Daumit, Gail L. ;
Dalcin, Arlene T. ;
Dickerson, Faith B. ;
Miller, Edgar R. ;
Evins, A. Eden ;
Cather, Corinne ;
Jerome, Gerald J. ;
Young, Deborah R. ;
Charleston, Jeanne B. ;
Gennusa, Joseph, V ;
Goldsholl, Stacy ;
Cook, Courtney ;
Heller, Ann ;
McGinty, Emma E. ;
Crum, Rosa M. ;
Appel, Lawrence J. ;
Wang, Nae-Yuh .
JAMA NETWORK OPEN, 2020, 3 (06)
[9]  
De Hert M, 2011, WORLD PSYCHIATRY, V10, P138
[10]   Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014 [J].
Hayes, Joseph F. ;
Marston, Louise ;
Walters, Kate ;
King, Michael B. ;
Osborn, David P. J. .
BRITISH JOURNAL OF PSYCHIATRY, 2017, 211 (03) :175-+